SPINOCEREBELLAR ATAXIAS
Clinical trials for SPINOCEREBELLAR ATAXIAS explained in plain language.
Never miss a new study
Get alerted when new SPINOCEREBELLAR ATAXIAS trials appear
Sign up with your email to follow new studies for SPINOCEREBELLAR ATAXIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare brain disease: drug may slow decline
Disease control OngoingThis study looks at whether the drug troriluzole can slow down spinocerebellar ataxia (SCA), a rare brain disease that affects movement and balance. About 900 people with SCA who took troriluzole for up to 3 years are compared to a group of untreated patients from a natural histo…
Matched conditions: SPINOCEREBELLAR ATAXIAS
Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Hope for rare brain disorder: new drug trial targets movement decline
Disease control OngoingThis study tests whether a daily pill called troriluzole can slow the worsening of movement problems in adults with spinocerebellar ataxia (SCA), a rare brain disease. About 299 people with certain types of SCA took either the drug or a placebo for 48 weeks. The main goal was to …
Matched conditions: SPINOCEREBELLAR ATAXIAS
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Can a phone app reveal how exercise helps the brain in ataxia?
Knowledge-focused TerminatedThis study was designed to see if a smartphone app called iBlink can measure how aerobic exercise affects learning in people with spinocerebellar ataxia, a group of brain disorders that cause disability. The app tracks a simple eye-blink test that relies on the cerebellum, the br…
Matched conditions: SPINOCEREBELLAR ATAXIAS
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 17, 2026 05:31 UTC
-
Mayo clinic launches massive genetic atlas for rare movement disorders
Knowledge-focused OngoingThis study collects blood and health information from 1,000 adults with ataxia or related genetic diseases (and their healthy family members) to build a research repository. The goal is to better understand how genes and symptoms connect in these rare conditions. No new treatment…
Matched conditions: SPINOCEREBELLAR ATAXIAS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:39 UTC